ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978